Neil Kumar

Chief Executive Officer, Eidos Therapeutics, Inc.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • BridgeBio BBIO993,327 shares6$65.9M at $66.39Sep 21, 2026
  • LianBio LIANY5,002,792 shares7$255.1K at $0.05Nov 9, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

  • Sep 17, 2026Sold 1,279 shares at $69.57 of BridgeBio6
  • Sep 17, 2026Sold 8,721 shares at $69.01 of BridgeBio6
  • Aug 19, 2026Sold 100 shares at $85.65 of BridgeBio8
  • Aug 19, 2026Sold 1,800 shares at $84.69 of BridgeBio8
  • Aug 19, 2026Sold 8,100 shares at $83.86 of BridgeBio8
  • Aug 18, 2026Sold 1,199 shares at $83.77 of BridgeBio8
  • Aug 18, 2026Sold 14,602 shares at $82.99 of BridgeBio8
  • Aug 18, 2026Sold 17,279 shares at $82.21 of BridgeBio8
  • Aug 18, 2026Sold 1,900 shares at $81.15 of BridgeBio8
  • Aug 16, 2026Shares withheld for tax 36,237 shares at $79.86 of BridgeBio9
  • Aug 16, 2026Exercised options 6,520 shares of BridgeBio9
  • Aug 16, 2026Exercised options 11,554 shares of BridgeBio9
  • Aug 16, 2026Exercised options 19,599 shares of BridgeBio9
  • Aug 16, 2026Exercised options 33,544 shares of BridgeBio9
  • Jun 5, 2026Sold 4,415 shares at $68.96 of BridgeBio10
  • Jun 5, 2026Sold 8,437 shares at $67.88 of BridgeBio10
  • Jun 5, 2026Sold 7,148 shares at $67.20 of BridgeBio10
  • Jun 5, 2026Sold 4,416 shares at $68.96 of BridgeBio10
  • Jun 5, 2026Sold 8,437 shares at $67.88 of BridgeBio10
  • Jun 5, 2026Sold 7,147 shares at $67.20 of BridgeBio10
  • Jun 4, 2026Sold 450 shares at $68.27 of BridgeBio10
  • Jun 4, 2026Sold 15,921 shares at $67.74 of BridgeBio10
  • Jun 4, 2026Sold 1,429 shares at $66.72 of BridgeBio10
  • Jun 4, 2026Sold 2,200 shares at $65.72 of BridgeBio10
  • Jun 4, 2026Sold 450 shares at $68.27 of BridgeBio10